NorthWest Biotherapeutics Inc (NWBO)

[iclight]

You can’t legitimately compare an immature line with dozens of censors with a mature line with three censors.

You do know that they actually have the mature data for that comparison, they just won't release it, right? It would need to show major separation after 36 months in the survival curves but there simply aren't enough patients who made it past 36 months to show efficacy or they would have overlaid those data sets and set things straight.

Moreover, the argument of comparison is for not, where NWBO’s position is that there is crossover efficacy.

Which they haven't proven as they won't release the complete data set for that either. Just like the don't have the complete datasets for the ECAs.

LL: "Everyone is living longer and it's not helping our trial". Selection bias is a bitch.